Results 181 to 190 of about 798,278 (191)
Some of the next articles are maybe not open access.
IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis
Journal of Allergy and Clinical Immunology, 2017Johann E Gudjonsson +2 more
exaly
The clinical, humanistic, and economic burden of generalized pustular psoriasis: a structured review
Expert Review of Clinical Immunology, 2020exaly
Treatments of Generalized Pustular Psoriasis: A Multicenter Study in Japan
Journal of Dermatology, 1999Akira Ohkawara +2 more
exaly
Long‐term efficacy of adalimumab in generalized pustular psoriasis
Journal of Dermatological Treatment, 2008Marina Talamonti, Arianna Zangrilli
exaly
Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
New England Journal of Medicine, 2011Hervé Bachelez +2 more
exaly
Imsidolimab for the treatment of generalized pustular psoriasis
British Journal of Dermatology, 2023openaire +2 more sources
[Generalized pustular psoriasis].
Bulletin de la Societe francaise de dermatologie et de syphiligraphie, 2003R, DEGOS, G, GARNIER, J, HEWITT, J, PY
openaire +3 more sources
Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis
New England Journal of Medicine, 2019David Burden, Akimichi Morita
exaly
Case report: Efficacy of tofacitinib in the treatment of generalized pustular psoriasis
Frontiers in MedicineTing Tang
exaly